Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example

The possible interchangeability of eye drops was analyzed using glaucoma medicines containing latanoprost as examples. It was shown that the reference and generic drugs could be identical with respect to composition of active ingredients when manufactured from the same pharmaceutical substance but c...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical chemistry journal 2018-02, Vol.51 (11), p.1021-1024
Main Authors: Bunyatyan, N. D., Filippova, O. V., Romanov, B. K., Prokof’ev, A. B.
Format: Article
Language:English
Subjects:
Analysis
Drug therapy
Drugs
Generic drugs
Glaucoma
Health aspects
Medicine
Ophthalmic drugs
Organic Chemistry
Pharmacology/Toxicology
Pharmacy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c307t-9cb56e3de97afec8099a235428f83ca151028eac386327b24d1793b08a50e0ec3
container_end_page 1024
container_issue 11
container_start_page 1021
container_title Pharmaceutical chemistry journal
container_volume 51
creator Bunyatyan, N. D.
Filippova, O. V.
Romanov, B. K.
Prokof’ev, A. B.
description The possible interchangeability of eye drops was analyzed using glaucoma medicines containing latanoprost as examples. It was shown that the reference and generic drugs could be identical with respect to composition of active ingredients when manufactured from the same pharmaceutical substance but could differ in the excipient composition, in particular, have a different buffer and osmolality that could produce differences in their clinical effects. An analysis of the literature showed that the therapeutic efficacy and safety could vary for pharmaceutically equivalent drugs. The lack of therapeutic equivalence on the background of pharmaceutical equivalence could be caused by the use of different packaging and different dosing systems. Therefore, results from clinical trials must be compared to confirm the interchangeability of eye drops.
doi_str_mv 10.1007/s11094-018-1732-6
format article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A528612126</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A528612126</galeid><sourcerecordid>A528612126</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-9cb56e3de97afec8099a235428f83ca151028eac386327b24d1793b08a50e0ec3</originalsourceid><addsrcrecordid>eNp9kMFKw0AQhhdRsFYfwFvAc-rMbpNsjqXUWqiIYMHbMtls2i3JpmRTtG_vlngRROYw8PN_A_Mxdo8wQYDs0SNCPo0BZYyZ4HF6wUaYZCLOQeAlGwHkGGMCH9fsxvs9QKAEH7G3letNp3fktoYKW9v-FK28Pxoffdp-Fy1rOuq2oejFlFZbF_KNt24brakn1x661vcR-YhctPii5lCbW3ZVUe3N3c8es83T4n3-HK9fl6v5bB1rAVkf57pIUiNKk2dUGS0hz4mLZMplJYUmTBC4NKSFTAXPCj4tMctFAZISMGC0GLOH4e6WaqOsq9q-I91Yr9Us4TJFjjwNrckfrTClaaxunalsyH8BOAA6vOY7U6lDZxvqTgpBnVWrQbUKqtVZtTozfGB86AaRndq3x86F7_-BvgEDEIAe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example</title><source>Springer Link</source><creator>Bunyatyan, N. D. ; Filippova, O. V. ; Romanov, B. K. ; Prokof’ev, A. B.</creator><creatorcontrib>Bunyatyan, N. D. ; Filippova, O. V. ; Romanov, B. K. ; Prokof’ev, A. B.</creatorcontrib><description>The possible interchangeability of eye drops was analyzed using glaucoma medicines containing latanoprost as examples. It was shown that the reference and generic drugs could be identical with respect to composition of active ingredients when manufactured from the same pharmaceutical substance but could differ in the excipient composition, in particular, have a different buffer and osmolality that could produce differences in their clinical effects. An analysis of the literature showed that the therapeutic efficacy and safety could vary for pharmaceutically equivalent drugs. The lack of therapeutic equivalence on the background of pharmaceutical equivalence could be caused by the use of different packaging and different dosing systems. Therefore, results from clinical trials must be compared to confirm the interchangeability of eye drops.</description><identifier>ISSN: 0091-150X</identifier><identifier>EISSN: 1573-9031</identifier><identifier>DOI: 10.1007/s11094-018-1732-6</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Analysis ; Drug therapy ; Drugs ; Generic drugs ; Glaucoma ; Health aspects ; Medicine ; Ophthalmic drugs ; Organic Chemistry ; Pharmacology/Toxicology ; Pharmacy</subject><ispartof>Pharmaceutical chemistry journal, 2018-02, Vol.51 (11), p.1021-1024</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2018</rights><rights>COPYRIGHT 2018 Springer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-9cb56e3de97afec8099a235428f83ca151028eac386327b24d1793b08a50e0ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bunyatyan, N. D.</creatorcontrib><creatorcontrib>Filippova, O. V.</creatorcontrib><creatorcontrib>Romanov, B. K.</creatorcontrib><creatorcontrib>Prokof’ev, A. B.</creatorcontrib><title>Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example</title><title>Pharmaceutical chemistry journal</title><addtitle>Pharm Chem J</addtitle><description>The possible interchangeability of eye drops was analyzed using glaucoma medicines containing latanoprost as examples. It was shown that the reference and generic drugs could be identical with respect to composition of active ingredients when manufactured from the same pharmaceutical substance but could differ in the excipient composition, in particular, have a different buffer and osmolality that could produce differences in their clinical effects. An analysis of the literature showed that the therapeutic efficacy and safety could vary for pharmaceutically equivalent drugs. The lack of therapeutic equivalence on the background of pharmaceutical equivalence could be caused by the use of different packaging and different dosing systems. Therefore, results from clinical trials must be compared to confirm the interchangeability of eye drops.</description><subject>Analysis</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Generic drugs</subject><subject>Glaucoma</subject><subject>Health aspects</subject><subject>Medicine</subject><subject>Ophthalmic drugs</subject><subject>Organic Chemistry</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><issn>0091-150X</issn><issn>1573-9031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMFKw0AQhhdRsFYfwFvAc-rMbpNsjqXUWqiIYMHbMtls2i3JpmRTtG_vlngRROYw8PN_A_Mxdo8wQYDs0SNCPo0BZYyZ4HF6wUaYZCLOQeAlGwHkGGMCH9fsxvs9QKAEH7G3letNp3fktoYKW9v-FK28Pxoffdp-Fy1rOuq2oejFlFZbF_KNt24brakn1x661vcR-YhctPii5lCbW3ZVUe3N3c8es83T4n3-HK9fl6v5bB1rAVkf57pIUiNKk2dUGS0hz4mLZMplJYUmTBC4NKSFTAXPCj4tMctFAZISMGC0GLOH4e6WaqOsq9q-I91Yr9Us4TJFjjwNrckfrTClaaxunalsyH8BOAA6vOY7U6lDZxvqTgpBnVWrQbUKqtVZtTozfGB86AaRndq3x86F7_-BvgEDEIAe</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Bunyatyan, N. D.</creator><creator>Filippova, O. V.</creator><creator>Romanov, B. K.</creator><creator>Prokof’ev, A. B.</creator><general>Springer US</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20180201</creationdate><title>Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example</title><author>Bunyatyan, N. D. ; Filippova, O. V. ; Romanov, B. K. ; Prokof’ev, A. B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-9cb56e3de97afec8099a235428f83ca151028eac386327b24d1793b08a50e0ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Analysis</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Generic drugs</topic><topic>Glaucoma</topic><topic>Health aspects</topic><topic>Medicine</topic><topic>Ophthalmic drugs</topic><topic>Organic Chemistry</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bunyatyan, N. D.</creatorcontrib><creatorcontrib>Filippova, O. V.</creatorcontrib><creatorcontrib>Romanov, B. K.</creatorcontrib><creatorcontrib>Prokof’ev, A. B.</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmaceutical chemistry journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bunyatyan, N. D.</au><au>Filippova, O. V.</au><au>Romanov, B. K.</au><au>Prokof’ev, A. B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example</atitle><jtitle>Pharmaceutical chemistry journal</jtitle><stitle>Pharm Chem J</stitle><date>2018-02-01</date><risdate>2018</risdate><volume>51</volume><issue>11</issue><spage>1021</spage><epage>1024</epage><pages>1021-1024</pages><issn>0091-150X</issn><eissn>1573-9031</eissn><abstract>The possible interchangeability of eye drops was analyzed using glaucoma medicines containing latanoprost as examples. It was shown that the reference and generic drugs could be identical with respect to composition of active ingredients when manufactured from the same pharmaceutical substance but could differ in the excipient composition, in particular, have a different buffer and osmolality that could produce differences in their clinical effects. An analysis of the literature showed that the therapeutic efficacy and safety could vary for pharmaceutically equivalent drugs. The lack of therapeutic equivalence on the background of pharmaceutical equivalence could be caused by the use of different packaging and different dosing systems. Therefore, results from clinical trials must be compared to confirm the interchangeability of eye drops.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s11094-018-1732-6</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-150X
ispartof Pharmaceutical chemistry journal, 2018-02, Vol.51 (11), p.1021-1024
issn 0091-150X
1573-9031
language eng
recordid cdi_gale_infotracmisc_A528612126
source Springer Link
subjects Analysis
Drug therapy
Drugs
Generic drugs
Glaucoma
Health aspects
Medicine
Ophthalmic drugs
Organic Chemistry
Pharmacology/Toxicology
Pharmacy
title Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A37%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interchangeability%20Issues%20with%20Glaucoma%20Medicines%20Using%20Latanoprost%20as%20an%20Example&rft.jtitle=Pharmaceutical%20chemistry%20journal&rft.au=Bunyatyan,%20N.%20D.&rft.date=2018-02-01&rft.volume=51&rft.issue=11&rft.spage=1021&rft.epage=1024&rft.pages=1021-1024&rft.issn=0091-150X&rft.eissn=1573-9031&rft_id=info:doi/10.1007/s11094-018-1732-6&rft_dat=%3Cgale_cross%3EA528612126%3C/gale_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c307t-9cb56e3de97afec8099a235428f83ca151028eac386327b24d1793b08a50e0ec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A528612126&rfr_iscdi=true